Holden Comprehensive Cancer Center - University of Iowa

University of Iowa Hospitals and Clinics

Iowa City, IA

Website

(888) 803-1766 Refer Patient

Filters

Personalize My Search

Sorting 8 by

Accepting patients

SELECT MDS-1

A Randomized, Double-blind, Placebo-controlled Phase 3 Study of Tamibarotene Plus Azacitidine Versus Placebo Plus Azacitidine in Newly Diagnosed, Adult Patients Selected for RARA-positive Higher-risk Myelodysplastic Syndrome (SELECT MDS-1)

Learn more

Hypomethylating Agents (HMA)
RAR-α / NR1B1
Phase 3

Accepting patients

Mismatched Related vs. Matched Unrelated Donor

A Multi-Center, Phase 3, Randomized Trial of Matched Unrelated Donor (MUD) Versus HLA-Haploidentical Related (Haplo) Myeloablative Hematopoietic Cell Transplantation for Children, Adolescents, and Young Adults (AYA) With Acute Leukemia or Myelodysplastic Syndrome (MDS)

Learn more

Allogeneic Stem Cell Transplant
Monoclonal Antibody
Phase 3

Get personalized results in 60 seconds

All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.

Help me find trials

Accepting patients

Activity Levels in Bone Marrow Transplant Patients

Learn more

Observational Trial

Accepting patients

LIMBER

A Phase 1, Open-Label, Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms

Learn more

BET Inhibitor
JAK1 Inhibitor
JAK2 Inhibitor
Phase 1

Accepting patients

Naïve T Cell Depletion

Multi-Center Phase II Randomized Controlled Trial of Naïve T Cell Depletion for Prevention of Chronic Graft-Versus-Host Disease in Children and Young Adults

Learn more